Pharmalex Nordic ApS

CVR 37541540 · Private limited company (ApS) · Active · Low risk

Pharmalex Nordic ApS is a Private limited company (ApS), founded on , based in Kongens Lyngby. The company is registered in the industry ikke-finansielle holdingselskaber. Our model estimates a bankruptcy risk of 0.6% over the next 12 months, which is 0.4 times the average for Danish companies. 9 annual reports have been published. The latest annual report (30 Sep 2025) shows equity of DKK -46.0m and a net result of DKK 1.7m. CEO: Christopher Gauglitz.

Bankruptcy risk for Pharmalex Nordic ApS

0.6%
probability of bankruptcy within 12 months
Low risk

0.4 × the average (1.41%) · higher risk than 66% of active Danish companies

Lowest riskHighest risk

Increases the risk

Negative equityYes · bankruptcy rate 17.5%2.0×
Equity vs. share capital< 0× · bankruptcy rate 17.3%2.0×
Time at current address0.5–1 yrs · bankruptcy rate 16.5%1.9×
Equity ratio-50%–0% · bankruptcy rate 14.8%1.7×
Moves in the last 2 years1 · bankruptcy rate 12.7%1.4×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
Other companies at the same address100+ · bankruptcy rate 11.5%1.3×
Annual reports filed late1 · bankruptcy rate 11.3%1.3×

Reduces the risk

Current ratio500%+ · bankruptcy rate 1.5%0.17×
CEOs in total (historical)5+ · bankruptcy rate 3.8%0.43×
Age (years)10–20 yrs · bankruptcy rate 3.9%0.45×
Share of late annual reports0.01%–25% · bankruptcy rate 4.5%0.51×
Auditor registered in CVRYes · bankruptcy rate 4.8%0.55×
Audit opted outNo · bankruptcy rate 4.8%0.55×
Capital changes2 · bankruptcy rate 5.2%0.59×
Loss for the yearNo · bankruptcy rate 5.3%0.60×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
37541540
Status
Active
Company type
Private limited company (ApS)
Founded
(10 years)
Address
Lyngby Hovedgade 10C
2800 Kongens Lyngby
Municipality
Lyngby-Taarbæk
Industry
Ikke-finansielle holdingselskaber (642120)
Bankruptcies in the industry: Ikke-finansielle holdingselskaber
Share capital
DKK 25k
Employees
1 (2018)
Auditor
Beierholm Godkendt Revisionspartnerselskab
Audit opted out
No

Warning signs

Annual reports filed late1 of 9
Missing annual reportNo
Negative equityYes
Equity ratio-22.7%
Current ratio503%
Moves (last 2 years)1
CEO changes in total8
CEO's previous bankruptcies0
Other companies at the address120
Going-concern uncertaintyNo

Financials and key figures

Financial year202520242023
Gross profitDKK 3.5mDKK 4.1mDKK 2.8m
Net profitDKK 1.7mDKK -88.4mDKK 6.2m
EquityDKK -46.0mDKK -47.7mDKK 40.8m
Total assetsDKK 202.9mDKK 195.4mDKK 273.7m
CashDKK 8.4mDKK 780k–
Short-term debtDKK 2.8mDKK 13.0m–
Avg. employees22–

Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · Beierholm.

Filed annual reports

Reporting periodPublishedDays after period end
1 Oct 2024 – 30 Sep 2025182
1 Oct 2023 – 30 Sep 2024143
1 Jan 2022 – 31 Dec 2022153
1 Jan 2021 – 31 Dec 202177
1 Jan 2020 – 31 Dec 202075
1 Jan 2019 – 31 Dec 201976
1 Jan 2018 – 31 Dec 201872
1 Jan 2017 – 31 Dec 201794
16 Mar 2016 – 31 Dec 2016129

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOChristopher GauglitzCurrent
CEOSolveig Blomvik
CEOAnette Langgaard Jacobsen
CEODr. Raphael Troost
CEOLaurent Maurice Robert Couston
Owner (100%)AmerisourceBergen International B.V.Current
Owner (100%)PharmaLex GmbH
Owner (15%)Vanturi ApS
Owner (67%)PharmaLex GmbH
Owner (20%)JAF INVEST ApS
Owner (5%)Vanturi ApS
Owner (100%)PharmaLex GmbH
Owner (100%)AB Netherlands Pharma Investments B.V.
AuditorBeierholm Godkendt RevisionspartnerselskabCurrent
FounderYES Multinational Holding Company GmbHCurrent

The CEOs' other companies

Solveig Blomvik – 2 other companies

Anette Langgaard Jacobsen – 5 other companies

Address history (3 moves)

Lyngby Hovedgade 10C, 2800 Kongens Lyngby
Agern Alle 24, 2970 Hørsholm
c/o LINDEQ DK A/S, Lyskær 8, 2730 Herlev
c/o LEAD Advokatpartnerselskab, Frederiksholms Kanal 20, st., 1220 København K

Employees per year

Number of employees at Pharmalex Nordic ApS per year112017: 120172018: 12018

Other companies at the same address

Similar companies in Lyngby-Taarbæk

Questions and answers about Pharmalex Nordic ApS

Has Pharmalex Nordic ApS gone bankrupt?

No, Pharmalex Nordic ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Pharmalex Nordic ApS?

Our model estimates a bankruptcy risk of 0.6% over the next 12 months (low risk), which is 0.4 times the average for Danish companies.

Who is the CEO of Pharmalex Nordic ApS?

Christopher Gauglitz is the CEO of Pharmalex Nordic ApS.

Who is the auditor of Pharmalex Nordic ApS?

Pharmalex Nordic ApS most recently used Beierholm Godkendt Revisionspartnerselskab.

When was Pharmalex Nordic ApS founded?

Pharmalex Nordic ApS was founded on 16 March 2016.

What is the equity of Pharmalex Nordic ApS?

Equity was DKK -46.0m according to the annual report for the period ending 30 September 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.